McGill Newsroom Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.
By Katherine Gombay, McGill Newsroom Research uncovers the inherently hierarchical nature of social media
McGill Newsroom McGill-led discovery could help fight obesity, metabolic disorders Researchers have uncovered a new molecular pathway for stimulating the body to burn fat – a discovery that could help fight obesity, diabetes and cardiovascular disease.
McGill Newsroom Guidance addresses key scientific, ethical, social, and policy challenges raised by new technologies and emerging areas of stem cell discovery and application
By Shawn Hayward, Montreal Neurological Institute and Hospital Discovery will aid development of treatments for this debilitating disease Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease. It is estimated that between two and 10 people per 100,000 in the general population have HSP, a disease characterized by weakness or spasticity in the lower limbs. HSP is caused by mutations inherited from one or both parents.
McGill University Health Centre New study reinforces importance of implementing screening in Quebec
It is with deep sadness that we inform you that Dr. Terry-Nan Tannenbaum passed away peacefully at her home on Thursday, March 17, 2016 surrounded by her family. Terry was as an Associate Professor in the Department of Family Medicine. Donations may be made to the "Dr. Terry Nan Tannenbaum Memorial Fund for Education" c/o the Jewish General Hospital Foundation (514-340-8251). On behalf of the McGill Department of Family Medicine, we would like to express our deepest sympathies.
As of today, 25,000 Syrian refugees will have arrived in Canada fleeing their war-torn country. Approximately 7,300 of those will stay in Quebec. Chunip Koo, a clinician nurse at the Montreal Neurological Hospital of the McGill University Health Centre (MNH-MUHC), and Dr. Zinab Gouda, physician in the Transitional Care Team and Secondary Care division of the MUHC Department of Family Medicine, describe their experience.
Researchers use optogenetics to produce pain relief by shutting off neurons with light The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
McGill Newsroom To support six research projects in fields from neuroscience to food safety and Arctic ecosystems
McGill Newsroom CREATE project to prepare graduates for high-skills work in surgical-devices industry A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.
By Fergus Grieve, McGill Newsroom Depression, metabolic factors combine to boost risk of developing diabetes, study finds Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.
McGill University Health Centre
By Tod Hoffman, Lady Davis Institute Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform